Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ongoing Phase 1b clinical trial in combination with chemotherapy in patients with platinum resistant ovarian cancer; and Phase 2 monotherapy trial for a tumor agnostic, predictive biomarker. The company's other lead product candidate includes ZN-c5, an oral selective estrogen receptor degrader that is in a Phase 1/2 clinical trial for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or advanced or metastatic breast cancer. In addition, it is involved in developing ZN-d5, a selective inhibitor of B-cell lymphoma 2 that is in a Phase 1 clinical trial for the treatment of non-Hodgkin's lymphoma and acute myelogenous leukemia; and ZN-e4, an irreversible inhibitor of mutant epidermal growth factor receptor, which is in Phase 1/2 clinical trial for the treatment of advanced non-small cell lung cancer. Further, the company is developing BCL-xL heterobifunctional degraders based on E3 ligases not expressed in platelets, allowing for the avoidance of dose-limiting thrombocytopenia associated with BCL-xL inhibitors. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Mayo Foundation for Medical Education and Research; SciClone Pharmaceuticals International (Cayman) Development Ltd.; Pfizer, Inc.; Eli Lilly and Company; GlaxoSmithKline, and Zentera Therapeutics (Cayman), Ltd. The company was incorporated in 2014 and is based in New York, New York. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Zentalis Pharmaceuticals Inc..
Zentalis Pharmaceuticals Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Zentalis Pharmaceuticals Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Zentalis Pharmaceuticals Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Zentalis Pharmaceuticals Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Zentalis Pharmaceuticals Inc. and all latest updates of the company are provided.
The 2025 version of Zentalis Pharmaceuticals Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Zentalis Pharmaceuticals Inc.- Key Facts
2.2 Zentalis Pharmaceuticals Inc.- Geographic Locations
2.3 Zentalis Pharmaceuticals Inc.- Subsidiaries and Affiliates
2.4 Zentalis Pharmaceuticals Inc.- Business Divisions
2.5 Zentalis Pharmaceuticals Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Zentalis Pharmaceuticals Inc. Strategic Analysis Review
3.1 Zentalis Pharmaceuticals Inc.- Key Strategies
3.2 Zentalis Pharmaceuticals Inc.- Company Outlook Statement
3.3 Zentalis Pharmaceuticals Inc.- SWOT Analysis
3.3.1 Zentalis Pharmaceuticals Inc.- Key Strengths
3.3.2 Zentalis Pharmaceuticals Inc.- Key Weaknesses
3.3.3 Zentalis Pharmaceuticals Inc.- Potential Opportunities
3.3.4 Zentalis Pharmaceuticals Inc.- Potential Threats
3.4 Zentalis Pharmaceuticals Inc.- Key Competitors
4. Business Description of the Company
4.1 Zentalis Pharmaceuticals Inc.- Business Overview
4.2 Zentalis Pharmaceuticals Inc.- Operations by Segment
5 Products and Services Details
5.1 Zentalis Pharmaceuticals Inc.- Key Products
5.2 Zentalis Pharmaceuticals Inc.- Key Service Areas
5.3 Zentalis Pharmaceuticals Inc.- Key Brands
6 Company Developments
6.1 Zentalis Pharmaceuticals Inc.- Company History
6.2 Zentalis Pharmaceuticals Inc.- Latest Developments
7 Financial Analysis
7.1 Zentalis Pharmaceuticals Inc.- Income Statements
7.2 Zentalis Pharmaceuticals Inc.- Balance Sheet
7.3 Zentalis Pharmaceuticals Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Zentalis Pharmaceuticals Inc.- Direct Competitors
8.2 Zentalis Pharmaceuticals Inc.- Competitor Financial Ratios comparison
8.3 Zentalis Pharmaceuticals Inc.- Competitor Stock Charts Comparison
8.4 Zentalis Pharmaceuticals Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
$50- 10%
$100- 20%
$200- 10%
$100- 20%
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!